nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.11.2019 | Original Article

Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors

verfasst von: A. Catalano, A. Gaudio, R. M. Agostino, N. Morabito, F. Bellone, A. Lasco

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Aromatase inhibitors (AIs) represent the first-line adjuvant therapy for hormone receptor-positive breast cancer (BC) women. AIs have been associated with an increased rate of fractures. The aim of our study was to investigate trabecular bone score (TBS) and bone quantitative ultrasound (QUS) measurements as bone quality surrogates in AIs users.

Methods

Sixty postmenopausal BC women starting AIs and forty-two controls (mean age 61.64 ± 8.33 years) were considered. Bone mineral density (BMD) at lumbar spine and femoral neck and TBS were measured by DXA; QUS-derived Amplitude-Dependent Speed of Sound (AD-SoS), Bone Transmission Time (BTT), and Ultrasound Bone Profile Index (UBPI) were assessed at phalangeal site; morphometric vertebral fractures (Vfx) by X-ray, serum bone-specific alkaline phosphatase (BSAP), and C-telopeptide of type 1 collagen (CTX) were also evaluated.

Results

After 18 months, changes of TBS vs baseline were significantly different between AIs group and controls [Δ TBS − 2.2% vs − 0.4%, respectively, p = 0.001]. AD-SoS, BTT and UBPI values decreased only in AIs’ group (− 3.7%, − 6.45%, −8.5%, vs baseline, respectively, p_all < 0.001). 3 Vfx occurred in AIs users and were associated with the greater TBS and AD-SoS modifications. In the AIs’ group, ΔTBS was associated with ΔAD-SoS (r = 0.58, p < 0.001) and ΔUBPI (r = 0.415, p = 0.001), but not with ΔBMD. Moreover, ΔTBS was independently predicted by ΔAD-SoS, after correcting for BMD, CTX and BSAP level changes (β = 0.37, SE = 2.44, p < 0.001).

Conclusions

TBS and phalangeal QUS provide useful information related to bone quality in AI-treated BC survivors and could be considered for fracture risk evaluation.

Rugo HS, Rumble RB, Macrae E et al (2016) Endocrine therapy for hormone receptor-positive metastatic breast cancer: American Society of Clinical Oncology Guideline. J Clin Oncol 34(25):3069–3103CrossRef

Amir E, Seruga B, Niraula S, Carlsson L, Ocaña A (2011) Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst 103(17):1299–1309CrossRef

Hadji P (2009) Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis. Crit Rev Oncol Hematol 69:73–82CrossRef

Hadji P, Aapro MS, Body JJ et al (2017) Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol 23(7):1–12CrossRef

Sakata S, Barkmann R, Lochmüller EM, Heller M, Glüer CC (2004) Assessing bone status beyond BMD: evaluation of bone geometry and porosity by quantitative ultrasound of human finger phalanges. J Bone Miner Res 19(6):924–930CrossRef

Krause M, Museyko O, Breer S et al (2014) Accuracy of trabecular structure by HR-pQCT compared to gold standard μCT in the radius and tibia of patients with osteoporosis and long-term bisphosphonate therapy. Osteoporos Int 25(5):1595–1606CrossRef

Shepherd JA, Schousboe JT, Broy SB, Engelke K, Leslie WD (2015) Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD. J Clin Densitom 18(3):274–286CrossRef

Malgo F, Hamdy NAT, Papapoulos SE, Appelman-Dijkstra NM (2017) Bone material strength index as measured by impact microindentation is low in patients with fractures irrespective of fracture site. Osteoporos Int 28(8):2433–2437CrossRef

Harvey NC, Glüer CC, Binkley N et al (2015) Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 78:216–224CrossRef

10.

Hans D, Barthe N, Boutroy S, Pothuaud L, Winzenrieth R, Krieg MA (2011) Correlations between trabecular bone score, measured using anteroposterior dual-energy X-ray absorptiometry acquisition, and 3-dimensional parameters of bone microarchitecture: an experimental study on human cadaver vertebrae. J Clin Densitom 14(3):302–312CrossRef

11.

Hans D, Šteňová E, Lamy O (2017) The Trabecular Bone Score (TBS) Complements DXA and the FRAX as a Fracture Risk Assessment Tool in Routine Clinical Practice. Curr Osteoporos Rep 15(6):521–531CrossRef

12.

Catalano A, Morabito N, Agostino RM et al (2017) Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors. Menopause 24(1):85–91CrossRef

13.

Catalano A, Gaudio A, Morabito N et al (2017) Quantitative ultrasound and DXA measurements in aromatase inhibitor-treated breast cancer women receiving denosumab. J Endocrinol Invest 40(8):851–857CrossRef

14.

Atteritano M, Lasco A, Mazzaferro S et al (2013) Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression. Intern Emerg Med 8(6):485–491CrossRef

15.

Catalano A, Morabito N, Basile G et al (2013) Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. Clin Cases Miner Bone Metab 10(3):191–194PubMed

16.

Guglielmi G, Njeh CF, de Terlizzi F (2003) Phalangeal quantitative ultrasound, phalangeal morphometricvariables, and vertebral fracture discrimination. Calcif Tissue Int 72(4):469–477CrossRef

17.

Guglielmi G, Rossini M, Nicolosi MG, Ragno A, Lentini G, de Terlizzi F (2013) Three-year prospective study on fracture risk in postmenopausal women by quantitative ultrasound at the phalanges. J Clin Densitom 16(3):341–346CrossRef

18.

Kanis JA, Johnell O, Oden A, De Laet C, De Terlizzi F (2005) Ten-year probabilities of clinical vertebral fractures according to phalangeal quantitative ultrasonography. Osteoporos Int 16(9):1065–1670CrossRef

19.

Glüer CC, Eastell R, Reid DM et al (2004) Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. J Bone Miner Res 19(5):782–793CrossRef

20.

Guglielmi G, de Terlizzi F (2009) Quantitative ultrasound in the assessment of osteoporosis. Eur J Radiol 71(3):425–431CrossRef

21.

Catalano A, Morabito N, Di Vieste G, Pintaudi B, Cucinotta D, Lasco A, Di Benedetto A (2013) Phalangeal quantitative ultrasound and metabolic control in pre-menopausal women with type 1 diabetes mellitus. J Endocrinol Invest 36(5):347–351PubMed

22.

Catalano A, Bellone F, Cicala G, Giandalia A, Morabito N, Cucinotta D, Russo GT (2017) Multiple fractures and impaired bone metabolism in Wolfram syndrome: a case report. Clin Cases Miner Bone Metab 14(2):254–257CrossRef

23.

Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8(9):1137–1148CrossRef

24.

Muschitz C, Kocijan R, Haschka J et al (2015) TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures. Bone 79:259–266CrossRef

25.

van Hellemond IEG, Geurts SME, Tjan-Heijnen VCG (2018) Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer. Curr Treat Options Oncol 19(5):26CrossRef

26.

Anderson KB, Holloway-Kew KL, Mohebbi M, Kotowicz MA, Hans D, Pasco JA (2018) Is trabecular bone score less affected by degenerative-changes at the spine thanlumbar spine BMD? Arch Osteoporos 13(1):127. https://doi.org/10.1007/s11657-018-0544-3 CrossRefPubMed

27.

Leslie WD, Anderson WA, Metge CJ, Manness LJ (2007) Maximizing Osteoporosis Management in Manitoba Steering Committee. Clinical risk factors for fracture in postmenopausal Canadian women: a population-based prevalence study. Bone 40(4):991–996CrossRef

28.

Liu J, Curtis EM, Cooper C, Harvey NC (2019) State of the art in osteoporosis risk assessment and treatment. J Endocrinol Invest. https://doi.org/10.1007/s40618-019-01041-6 CrossRefPubMedPubMedCentral

29.

Boutroy S, Hans D, Sornay-Rendu E, Vilayphiou N, Winzenrieth R, Chapurlat R (2013) Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study. Osteoporos Int 24(1):77–85 CrossRef

30.

María RS, Marta PM, Sonia S et al (2016) TBS and BMD at the end of AI-therapy: a prospective study of the B-ABLE cohort. Bone 92:1-8CrossRef

31.

Mariotti V, Page DB, Davydov O et al (2016) Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone score. J Bone Oncol 7:32–37CrossRef

32.

Ramalho J, Marques IDB, Hans D et al (2018) The trabecular bone score: relationships with trabecular and cortical microarchitecture measured by HR-pQCT and histomorphometry in patients with chronic kidney disease. Bone 116:215–220CrossRef

33.

34.

Catalano A, Martino G, Morabito N, Scarcella C, Gaudio A, Basile G, Lasco A (2017) Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach. Drugs Aging 34(10):755–765CrossRef

35.

Catalano A, Morabito N, Atteritano M, Basile G, Cucinotta D, Lasco A (2012) Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis. Calcif Tissue Int 90(4):279–285CrossRef

36.

Martino G, Catalano A, Bellone F et al (2018) Quality of life in postmenopausal women: which role for vitamin D? Mediterr J Clin Psychol 6(2):85. https://doi.org/10.6092/2282-1619/2018.6.1875 CrossRef

Titel: Trabecular bone score and quantitative ultrasound measurements in the assessment of bone health in breast cancer survivors assuming aromatase inhibitors
verfasst von: A. Catalano
A. Gaudio
R. M. Agostino
N. Morabito
F. Bellone
A. Lasco
Publikationsdatum: 01.11.2019
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 11/2019
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-019-01063-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2019

Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation

Thyroid nodules with Hürthle cells: the malignancy risk in relation to the FNA outcome category

Measurement of urinary free cortisol by LC–MS–MS: adoption of a literature reference range and comparison with our current immunometric method

Classifying pain in transoral endoscopic thyroidectomy

Effect of long- and short-chain perfluorinated compounds on cultured thyroid cells viability and response to TSH